Filing Details

Accession Number:
0000950170-25-075255
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-20 16:35:07
Reporting Period:
2025-05-16
Filing Date:
2025-05-20
Accepted Time:
2025-05-20 16:35:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828673 Hcw Biologics Inc. HCWB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1822095 M Gary Winer C/O Hcw Biologics Inc
2929 N. Commerce Parkway
Miramar FL 33025
No No No No
Transaction Summary
Purchased: 1,342 shares Avg. Price: $7.45 Total Value: $9,997.90
Number of Shares After Transactions: 4,075 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-16 1,342 $7.45 4,075 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares were issued pursuant to a conversion of Unsecured Convertible Promissory Notes which were issued to six holders through a Company financing of an aggregate principal of $270,000 in one-year Notes. The Notes contained a mandatory conversion provision, which resulted in the Notes converting into shares of common stock at a mandatory conversion price of $7.45 per share as set by the registered offering. The Notes converted after the closing of the Company's registered offering on May 15, 2025. The conversion transaction also included an allocated portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company.